Form 8-K
8-K — New ERA Energy & Digital, Inc.
Accession: 0001213900-26-042161
Filed: 2026-04-10
Period: 2026-04-09
CIK: 0002028336
SIC: 1311 (CRUDE PETROLEUM & NATURAL GAS)
Item: Regulation FD Disclosure
Item: Other Events
Item: Financial Statements and Exhibits
Documents
8-K — ea0285756-8k_newera.htm (Primary)
EX-1.1 — UNDERWRITING AGREEMENT, DATED AS OF APRIL 9, 2026, BY AND BETWEEN NEW ERA ENERGY & DIGITAL, INC. AND NORTHLAND SECURITIES, INC., AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERS NAMED IN SCHEDULE I THERETO (ea028575601ex1-1.htm)
EX-5.1 — OPINION OF ANTHONY, LINDER & CACOMANOLIS, PLLC (ea028575601ex5-1.htm)
EX-99.1 — PRESS RELEASE, DATED APRIL 9, 2026 (ea028575601ex99-1.htm)
GRAPHIC (ea028575601_ex5-1img1.jpg)
GRAPHIC (ea028575601_ex99-1img1.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0285756-8k_newera.htm · Sequence: 1
false
0002028336
0002028336
2026-04-09
2026-04-09
0002028336
us-gaap:CommonStockMember
2026-04-09
2026-04-09
0002028336
NUAI:WarrantsMember
2026-04-09
2026-04-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the
Securities Exchange Act of 1934
April 9, 2026
Date of Report (Date of earliest event reported)
NEW ERA ENERGY & DIGITAL, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada
001-42433
99-3749880
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification Number)
200 N. Loraine Street, Suite 1324
Midland, TX
79701
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including
area code: ( 432 ) 695-6997
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
NUAI
The Nasdaq Stock Market LLC
Warrants
NUAIW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On
April 9, 2026, New Era Energy & Digital, Inc. (the “Company”) issued a press release announcing the pricing of an underwritten
public offering of 29,850,746 shares of its common stock, par value $0.0001 per share (“Common Stock”), at a price to the
public of $3.35 per share, pursuant to a registration statement on Form S-3 (File No. 333-292892) (the “Registration Statement”)
filed with the U.S. Securities and Exchange Commission (the “Commission”) on January 23, 2026 and declared effective on January
30, 2026, including the prospectus forming a part of the Registration Statement, and a preliminary prospectus supplement, which was filed
with the Commission on April 8, 2026. A copy of the press release announcing the pricing of the Offering (as defined below) is furnished
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The
information in this Current Report on Form 8-K under Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed”
for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific referencing in such filing.
Item 8.01 Other Events.
On
April 9, 2026, the Company and Northland Securities, Inc., as representative of the several underwriters named in Schedule I thereto (collectively,
the “Underwriters”), entered into an underwriting agreement (the “Underwriting Agreement”), pursuant to which
the Company agreed to sell to the Underwriters, and the Underwriters agreed to purchase from the Company, subject to and upon the terms
and conditions set forth therein, 29,850,746 shares of Common Stock (the “Offering”) at the public offering price less underwriting
discounts and commissions.
The
material terms of the Offering are described in the prospectus supplement, dated April 9, 2026 (the “Prospectus”), to be filed
by the Company with the Commission on or around April 9, 2026, pursuant to Rule 424(b) under the Securities Act.
As
described in the Prospectus, the Company expects to receive net proceeds from the Offering of approximately $93.4 million and
intends to use the net proceeds of the Offering to repay all outstanding borrowings under its senior secured convertible promissory
note (the “Convertible Note”) with SharonAI, Inc. (“SharonAI”) and the remainder, if any, for general
corporate purposes. The Convertible Note was incurred as part of the acquisition consideration under the previously announced
Membership Interest Purchase Agreement, dated as of January 16, 2026, with SharonAI and matures on June 30, 2026 and has an interest
rate of 10% per annum.
Further,
pursuant to the Underwriting Agreement, the Company has granted the Underwriters a 30-day option to purchase, at the public offering price
less underwriting discounts, up to 4,477,611 additional shares of Common Stock and has agreed not to sell, transfer or otherwise dispose
of any shares of Common Stock for a period beginning from the date of the Underwriting Agreement and ending 90 days after the date of
the Underwriting Agreement without first obtaining the written consent of the Underwriters, subject to certain exceptions.
The
Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination
provisions. The Company has agreed to indemnify the Underwriters against certain liabilities, including liabilities under the Securities
Act, and to contribute to payments the Underwriters may be required to make because of any of those liabilities.
The
foregoing description is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is attached as Exhibit
1.1 to this Current Report on Form 8-K and incorporated into this Item 8.01 by reference.
A
copy of the legal opinion of Anthony, Linder & Cacomanolis, PLLC relating to the validity of the issuance and sale of the Common Stock
in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K and is filed with reference to, and is hereby incorporated
by reference into, the Registration Statement.
1
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
EXHIBIT
DESCRIPTION
1.1
Underwriting Agreement, dated as of April 9, 2026, by and between New Era Energy & Digital, Inc. and Northland Securities, Inc., as representative of the several underwriters named in Schedule I thereto
5.1
Opinion of Anthony, Linder & Cacomanolis, PLLC
23.1
Consent of Anthony, Linder & Cacomanolis, PLLC (included as part of Exhibit 5.1 hereto).
99.1
Press Release, dated April 9, 2026.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEW ERA ENERGY & DIGITAL, INC.
Date: April 10, 2026
By:
/s/ E. Will Gray II
E. Will Gray II
Chief Executive Officer
3
EX-1.1 — UNDERWRITING AGREEMENT, DATED AS OF APRIL 9, 2026, BY AND BETWEEN NEW ERA ENERGY & DIGITAL, INC. AND NORTHLAND SECURITIES, INC., AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERS NAMED IN SCHEDULE I THERETO
EX-1.1
Filename: ea028575601ex1-1.htm · Sequence: 2
Exhibit 1.1
Execution Version
New Era Energy & Digital, Inc.
29,850,746 Shares of Common Stock, par value $0.0001
per share
Underwriting Agreement
April 9, 2026
NORTHLAND SECURITIES, INC.
As Representative of the several Underwriters
listed in Schedule I hereto
c/o Northland Securities, Inc.
150 South Fifth Street, Suite 3300
Minneapolis, Minnesota 55402
Ladies and Gentlemen:
New Era Energy & Digital,
Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule I
hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of
29,850,746 shares (the “Underwritten Shares”) of common stock, par value $0.0001 per share (“Common Stock”), of
the Company and, at the option of the Underwriters, up to an additional 4,477,611 shares of Common Stock (the “Option Shares”).
The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding
after giving effect to the sale of the Shares are referred to herein as the “Stock.”
The Company hereby confirms its
agreement with the several Underwriters concerning the purchase and sale of the Shares, as follows:
1. Registration
Statement. The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) under the
Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”),
a registration statement on Form S-3 (File No. 333-292892), including a prospectus, relating to certain securities of the Company, including
the Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant
to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (“Rule
430 Information”), is referred to herein as the “Registration Statement;” and as used herein, the term “Preliminary
Prospectus” means each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any
prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act, the prospectus included in the Registration Statement
at the time of its effectiveness that omits Rule 430 Information (the “Base Prospectus”) and the prospectus supplement dated
April 9, 2026 relating to the Shares, and the term “Prospectus” means the Base Prospectus and the prospectus supplement in
the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation
of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act
(the “Rule 462 Registration Statement”), then any reference herein to the term “Registration Statement” shall
be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting agreement (this “Agreement”)
to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement
or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to “amend,” “amendment”
or “supplement” with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to
refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations
of the Commission thereunder (collectively, the “Exchange Act”) that are deemed to be incorporated by reference therein. Capitalized
terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus.
At or prior to the Applicable
Time (as defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex
A, the “Pricing Disclosure Package”): a Preliminary Prospectus dated April 8, 2026 and any issuer free writing prospectus
as defined in Rule 433 of the Securities Act, if any, that the parties thereto shall hereafter expressly agree in writing to treat as
part of the Pricing Disclosure Package.
“Applicable Time”
means 6:30 A.M., New York City time, on April 9, 2026.
2. Purchase
of the Shares.
(a) The
Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees,
severally and not jointly, to purchase at a price per Share of $3.149 (the “Purchase Price”) from the Company the respective
number of Underwritten Shares set forth opposite such Underwriter’s name in Schedule I hereto.
In addition, the Company agrees
to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase,
severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or
distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares.
If any Option Shares are to be
purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio
to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter
in Schedule I hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of Underwritten
Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional
Shares as the Representative in its sole discretion shall make.
The Underwriters may exercise
the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the
date of the Prospectus, by written notice from the Representative to the Company. Such notice shall set forth the aggregate number of
Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for,
which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later
than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance
with the provisions of Section 10 hereof). Any such notice shall be given at least two business days prior to the date and time of
delivery specified therein, provided that if such date and time of delivery are the same as the Closing Date, such notice may be given
one business day prior to such date and time of delivery.
(b) The
Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms
set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or
through any affiliate of an Underwriter.
(c) Payment
for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representative
in the case of the Underwritten Shares at 10:00 A.M. New York City time on April 10, 2026, or at such other time or such other date, not
later than the fifth business day thereafter, as the Representative and the Company may agree upon in writing or, in the case of the Option
Shares, on the date and at the time specified by the Representative in the written notice of the Underwriters’ election to purchase
such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the “Closing Date,”
and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the “Additional
Closing Date.”
Payment for the Shares to be purchased
on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representative for the respective
accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with
any transfer taxes payable in connection with the sale of such Shares by the Underwriters duly paid by the Company. Delivery of the Shares
shall be made in book-entry form registered in such names and in such denominations as the Representative shall request in writing not
later than one full business day prior to the Closing Date or Additional Closing Date, as applicable, through the facilities of The Depository
Trust Company (“DTC”) unless the Representative shall otherwise instruct.
2
(d) The
Company acknowledges and agrees that the Representative and the other Underwriters are acting solely in the capacity of an arm’s
length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with
determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person.
Additionally, neither the Representative nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment,
accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall
be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representative
nor the other Underwriters shall have any responsibility or liability to the Company with respect thereto. Any review by the Representative
and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Underwriters and shall not be on behalf of the Company.
3. Representations
and Warranties of the Company. The Company represents and warrants to each Underwriter that:
(a) Compliance
with Registration Requirements. The Registration Statement has become effective under the Securities Act. The Company has complied,
to the Commission’s satisfaction with all requests of the Commission for additional or supplemental information, if any. No stop
order suspending the effectiveness of the Registration Statement is in effect and no proceedings for such purpose or pursuant to Section 8A
of the Securities Act against the Company or related to the offering of the Shares have been instituted or are pending or, to the knowledge
of the Company, are contemplated or threatened by the Commission. At the time the Company’s Annual Report on Form 10-K for the year
ended December 31, 2025 (the “Annual Report”) was filed with the Commission, or, if later, at the time the Registration Statement
was originally filed with the Commission, the Company met the then-applicable requirements for use of Form S-3 under the Securities Act.
The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, at the time they were or hereafter are filed with the Commission, or became effective under the Exchange Act, as the case
may be, complied and will comply in all material respects with the requirements of the Exchange Act, and none of such documents contained
any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the
Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform
in all material respects to the requirements of the Exchange Act and will not include any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(b) Disclosure.
Each Preliminary Prospectus and the Prospectus when filed complied in all material respects with the Securities Act and, if filed by electronic
transmission pursuant to the Commission’s Electronic Data Gathering Analysis and Retrieval system (“EDGAR”), was identical
(except as may be permitted by Regulation S-T under the Securities Act) to the copy thereof delivered to the Underwriters for use in connection
with the offer and sale of the Shares. Each of the Registration Statement and any post-effective amendment thereto, at the time it became
or becomes effective, complied and will comply in all material respects with the Securities Act and did not and will not include any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading. As of the Applicable Time, the Pricing Disclosure Package (including any preliminary prospectus wrapper) did not, and
at the Closing Date and at each applicable Additional Closing Date, will not, include any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Prospectus (including any Prospectus wrapper), as of its date, did not, and at the Closing Date and at each applicable Additional
Closing Date, will not, include any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set
forth in the three immediately preceding sentences do not apply to statements in or omissions from the Registration Statement or any post-effective
amendment thereto, or the Prospectus or the Pricing Disclosure Package, or any amendments or supplements thereto, made in reliance upon
and in conformity with written information relating to any Underwriter furnished to the Company in writing by the Representative expressly
for use therein, it being understood and agreed that the only such information consists of the information described in Section 7(b)
below. There are no contracts or other documents required to be described in the Pricing Disclosure Package or the Prospectus or to be
filed as an exhibit to the Registration Statement which have not been described or filed as required.
3
(c) Free
Writing Prospectuses; Road Show. As of the determination date referenced in Rule 164(h) under the Securities Act, the Company is an
“ineligible issuer” in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities
Act. The Company shall not prepare, use, file or refer to any free writing prospectuses. If at any time when a prospectus is required
by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar
rule) in connection with sales of Shares contemplated under this Agreement (but in any event if at any time through and including each
Closing Date) there occurred or occurs an event or development as a result the Preliminary Prospectus would conflict with the information
contained in the Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to
state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such time, not
misleading, the Company shall promptly amend or supplement the Preliminary Prospectus to eliminate or correct such conflict or so that
the statements in the Preliminary Prospectus as so amended or supplemented will not include an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such
time, not misleading, as the case may be; provided, however, that prior to amending or supplementing the Preliminary Prospectus, the Company
shall furnish to the Representative for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy
of such proposed amended or supplemented Preliminary Prospectus, and the Company shall not file, use or refer to such amended or supplemented
Preliminary Prospectus without the Representative’s prior written consent, which consent shall not be unreasonably withheld.
(d) Distribution
of Offering Material By the Company. Prior to the latest of (i) the expiration or termination of the option granted to the several
Underwriters in Section 2 and (ii) the completion of the Underwriters’ distribution of the Shares, the Company has not distributed
and will not distribute any offering material in connection with the offering and sale of the Shares other than the Registration Statement,
the Pricing Disclosure Package or the Prospectus and any oral or written communication with potential investors undertaken in reliance
on either Section 5(d) of, or Rule 163B under, the Securities Act (each, a “Testing-the-Waters Communication” and, if
a written communication, a “Written Testing-the-Waters Communication”). The Company has not distributed or approved for distribution
any Written Testing-the-Waters Communications other than those listed on Annex B hereto. Each Written Testing-the-Waters Communication,
when considered together with the Pricing Disclosure Package, did not, as of the Applicable Time, include any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.
(e) The
Underwriting Agreement. This Agreement has been duly authorized, executed and delivered by the Company.
(f) Authorization
of the Shares. (i) The Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered
by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable; and (ii) and,
except as have been duly waived or as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
the issuance and sale of the Shares is not subject to any preemptive rights, rights of first refusal or other similar rights to subscribe
for or purchase the Shares.
(g) No
Applicable Registration or Other Similar Rights. There are no persons with registration or other similar rights to have any equity
or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this Agreement, except
for such rights as have been duly waived.
4
(h) No
Material Adverse Change. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
subsequent to the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package and
the Prospectus: (i) there has been no material adverse change, or any development that would reasonably be expected to result in a material
adverse change, in the condition, financial or otherwise, or in the earnings, business, properties, operations, assets, liabilities or
prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered
as one entity (any such change being referred to herein as a “Material Adverse Change”); (ii) the Company and its subsidiaries,
considered as one entity, have not incurred any material liability or obligation, indirect, direct or contingent, including without limitation
any losses or interference with its business from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered
by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material, individually or in
the aggregate, to the Company and its subsidiaries, considered as one entity, or has entered into any transactions not in the ordinary
course of business; and (iii) there has not been any material decrease in the capital stock or any material increase in any short-term
or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid
or made by the Company or, except for dividends paid to the Company or other subsidiaries, by the Company’s subsidiaries on any
class of capital stock, or any repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock.
(i) Independent
Accountants. Weaver and Tidwell, L.L.P., which has expressed its opinion with respect to the financial statements (which term as used
in this Agreement includes the related notes thereto) filed with the Commission as a part of the Registration Statement, the Pricing Disclosure
Package and the Prospectus, is (i) an independent registered public accounting firm as required by the Securities Act, the Exchange Act,
and the rules of the Public Company Accounting Oversight Board (“PCAOB”), (ii) in compliance with the applicable requirements
relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities Act and (iii) a registered public
accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration
to be withdrawn.
(j) Financial
Statements. The financial statements filed with the Commission as a part of the Registration Statement, the Pricing Disclosure Package
and the Prospectus present fairly, in all material respects, the consolidated financial position of the Company and its subsidiaries as
of the dates indicated and the results of their operations, changes in stockholders’ equity and cash flows for the periods specified.
Such financial statements have been prepared in conformity with generally accepted accounting principles as applied in the United States
(“GAAP”), applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related
notes thereto. All disclosures contained in the Registration Statement, any preliminary prospectus or the Prospectus, that constitute
non-GAAP financial measures (as defined by the rules and regulations under the Securities Act and the Exchange Act) comply with Regulation
G under the Exchange Act and Item 10 of Regulation S-K under the Securities Act, as applicable.
(k) Company’s
Accounting System. The Company and its subsidiaries make and keep accurate books and records and maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general
or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general
or specific authorization; (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for
in all material respects and is prepared in accordance with the Commission’s rules and guidelines applicable thereto. As disclosed
in the Annual Report, the Company’s management identified material weaknesses in the Company’s internal control over financing
reporting and concluded that such internal control over financing reporting was not effective as of such date. The Company has taken action
to remediate the material weakness and is still in the process of completing such remediation. The Company believes the steps taken to
date are reasonable and appropriate given the size and complexity of the Company.
5
(l) Disclosure
Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting. Except as described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, the Company has established and maintains disclosure controls and procedures
(as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are designed to ensure that material information relating to
the Company, including its consolidated subsidiaries, is made known to the Company’s principal executive officer and its principal
financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange
Act are being prepared; (ii) have been evaluated by management of the Company for effectiveness as of the end of the Company’s most
recent fiscal quarter; and (iii) are effective in all material respects to perform the functions for which they were established. Since
the end of the Company’s most recent audited fiscal year, there have been no significant deficiencies or material weakness in the
Company’s internal control over financial reporting (whether or not remediated) and no change in the Company’s internal control
over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control
over financial reporting. The Company is not aware of any change in its internal control over financial reporting that has occurred during
its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting. As disclosed in the Annual Report, the Company’s management, including the Chief Executive Officer
and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were not effective as of such date.
The Company has taken action to remediate the material weakness and is still in the process of completing such remediation. The Company
believes the steps taken to date are reasonable and appropriate given the size and complexity of the Company.
(m) Incorporation
and Good Standing of the Company. The Company has been duly incorporated and is validly existing as a corporation in good standing
under the laws of the State of Nevada and has the corporate power and authority to own, lease and operate its properties and to conduct
its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and to enter into and perform
its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good standing
in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct
of business, except where the failure to be so qualified or in good standing, as the case may be, or to have such power or authority would
not, individually or in the aggregate, have a Material Adverse Effect (defined below).
(n) Subsidiaries.
The Company’s “subsidiaries” (for purposes of this Agreement, as defined in Rule 405 under the Securities Act) have
been duly incorporated or organized, as the case may be, and are validly existing and in good standing (where such concept is recognized)
under the laws of the jurisdiction of its incorporation or organization and have the power and authority (corporate or other) to own,
lease and operate their properties and to conduct their business as described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus. The Company’s subsidiaries are duly qualified to transact business and are in good standing (where such concept
is recognized) in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure to be so qualified or in good standing, as the case may be, or have such power or
authority would not, individually or in the aggregate, have a Material Adverse Effect. All of the issued and outstanding capital stock
or other equity or ownership interests of the Company’s subsidiaries have been duly authorized and validly issued, are fully paid
and nonassessable and are owned by the Company, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse
claim, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The Company does not own
or control, directly or indirectly, any corporation, association or other entity other than Texas Critical Data Centers LLC and the subsidiaries
listed in Exhibit 21.1 to the Annual Report. The subsidiaries listed in Schedule II to this Agreement are the only significant subsidiaries
of the Company.
(o) Capitalization
and Other Capital Stock Matters. The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration
Statement, the Pricing Disclosure Package and the Prospectus (other than for subsequent issuances, if any, pursuant to employee benefit
plans or inducement awards, or upon the exercise of outstanding options or warrants, or upon the conversion of any convertible promissory
notes, in each case described in the Registration Statement, the Pricing Disclosure Package and the Prospectus). The Shares, when issued
pursuant to the terms of this Agreement will conform, in all material respects, to the description thereof contained in the Pricing Disclosure
Package. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and nonassessable
and have been issued in compliance with all applicable federal and state securities laws. None of the outstanding shares of Common Stock
were issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities
of the Company. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to
purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or its subsidiaries
other than those described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The descriptions of the Company’s
stock option, stock bonus and other stock plans or arrangements (each, a “Company Stock Plan”), and the options or other rights
granted thereunder, set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus accurately and fairly presents,
in all material respects, the information required to be shown with respect to such plans, arrangements, options and rights.
6
(p) Stock
Exchange Listing. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the
Nasdaq Stock Market (the “Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq, nor has the Company received
any notification that the Commission or the Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge,
it is in compliance with all applicable listing requirements of the Nasdaq.
(q) Non-Contravention
of Existing Instruments; No Further Authorizations or Approvals Required. Neither the Company nor its subsidiaries is in violation
of its charter or by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, or is in default
(or, with the giving of notice or lapse of time, would be in default) (“Default”) under any indenture, loan, credit agreement,
note, lease, license agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security
agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company
or its subsidiaries is a party or by which it or any of them may be bound, or to which any of their respective properties or assets are
subject (each, an “Existing Instrument”), except for such Defaults as could not be expected, individually or in the aggregate,
to have a material adverse effect on the condition (financial or other), earnings, business, properties, operations, assets, liabilities
or prospects of the Company and its subsidiaries, considered as one entity (a “Material Adverse Effect”). The Company’s
execution, delivery and performance of this Agreement, consummation of the transactions contemplated hereby and by the Registration Statement,
the Pricing Disclosure Package and the Prospectus and the issuance and sale of the Shares (including the use of proceeds from the sale
of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the caption “Use
of Proceeds”) (i) have been duly authorized by all necessary corporate action and will not result in any violation of the provisions
of the charter or by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company
or any subsidiary (ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below)
under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or of its
subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument, except as could not be expected, individually
or in the aggregate, to have a Material Adverse Effect and (iii) will not result in any violation of any law, administrative regulation
or administrative or court decree applicable to the Company or its subsidiaries, except for such violations as would not be expected,
individually or in the aggregate, to have a Material Adverse Effect. No consent, approval, authorization or other order of, or registration
or filing with, any court or other governmental or regulatory authority or agency, is required for the Company’s execution, delivery
and performance of this Agreement and the consummation of the transactions contemplated hereby and by the Registration Statement, the
Pricing Disclosure Package and the Prospectus, except such as have been obtained or made or will be made by the Company under the Securities
Act, as have been obtained or will be made by the Company with the Nasdaq, and such as may be required under applicable state securities
or blue sky laws or Financial Industry Regulatory Authority, Inc. (“FINRA”) rules. As used herein, a “Debt Repayment
Triggering Event” means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder
of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the
repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or its subsidiaries.
(r) Compliance
with Laws. The Company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except
where failure to be so in compliance could not be expected, individually or in the aggregate, to have a Material Adverse Effect.
(s) No
Material Actions or Proceedings. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, there is no action, suit, proceeding, inquiry or investigation brought by or before any governmental entity now pending or,
to the knowledge of the Company, threatened, against or affecting the Company or its subsidiaries, which if determined adversely to the
Company or its subsidiaries would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or materially
and adversely affect the consummation of the transactions contemplated by this Agreement or the performance by the Company of its obligations
hereunder; and the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary is a party or
of which any of their respective properties or assets is the subject, including ordinary routine litigation incidental to the business,
if determined adversely to the Company, would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. No material labor dispute with the employees of the Company or its subsidiaries exists or, to the knowledge of the Company, is
threatened or imminent.
7
(t) Intellectual
Property. (i) The Company and its subsidiaries own or have the right to use all patents, patent
rights, statutory invention rights, community designs, invention disclosures, rights in utility models and industrial designs, inventions,
registered and unregistered copyrights (including copyrights in software), intellectual property rights in technology and software, data,
knowhow (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks, business names, trade names, logos, slogans, trade dress, design rights, Internet domain names, social media
accounts, any other designations of source or origin, and any applications (including provisional applications), registrations, or renewals
for any of the foregoing, rights to publicity and privacy and/or other intellectual property (collectively, “Intellectual Property”)
used in or necessary for the conduct of their respective businesses; (ii) the Company’s and its subsidiaries’ conduct of their
respective businesses does not and has not, in the last three (3) years, infringed, misappropriated or otherwise violated, any Intellectual
Property of any person in any manner that would be reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect; (iii) the Company and its subsidiaries have not received any written notice of any claim relating to Intellectual Property, including
any claim alleging any infringement, misappropriation or other violation of, or conflict regarding, any Intellectual Property of a third
party; and (iv) to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being and has not
been infringed, misappropriated or otherwise violated by any person and there is no pending or threatened action, suit, proceeding or
claim by the Company or any of its subsidiaries against a third party regarding the foregoing. (I) The Company and its subsidiaries have
complied in all material respects with the terms of each agreement material to the operation of their respective businesses pursuant to
which Intellectual Property has been licensed to the Company or its subsidiaries, (II) neither the Company nor any of its subsidiaries
has received any written notice alleging any such noncompliance, and (III) all such agreements are in full force and effect, except where
the failure to be in full force and effect would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect. To the knowledge of the Company, all Intellectual Property owned by the Company (such Intellectual Property, the “Company
Intellectual Property”) is valid, subsisting and enforceable and there is no pending or, to the Company’s knowledge, threatened
action, suit, proceeding or claim by any third party challenging the validity, ownership, registrability, scope or enforceability of any
Company Intellectual Property. All material Company Intellectual Property has been duly maintained in all material respects and is in
full force and effect, and all actions or fees necessary to prosecute or maintain such Company Intellectual Property have been timely
taken, met or paid. Each person who is or was an employee or contractor of the Company or any of its subsidiaries and who is, was or,
in the case of current employees and contractors, is reasonably expected to be involved in the creation or development of any material
Intellectual Property for or on behalf of the Company has executed a valid, written agreement containing an effective assignment to the
Company or any of its subsidiaries or other legal obligation that grants the Company and its subsidiaries ownership of the person’s
rights in and to such Intellectual Property. The Company has taken commercially reasonable steps to maintain the confidentiality of the
trade secrets and other confidential Intellectual Property material to the business of the Company and its subsidiaries. No Intellectual
Property has been obtained or is being used by the Company or its subsidiaries in violation of any material contractual obligations binding
on the Company or its subsidiaries or in violation of any contractual rights of any person. No university, military, educational institution,
research center, governmental entity or other organization has funded, sponsored or contributed to research and development conducted
in connection with the business of the Company or any of its subsidiaries in a manner that (1) would give rise to a claim of right to,
ownership of or other lien on any Company Intellectual Property or (2) would affect the proprietary nature of any Company Intellectual
Property or materially restrict the ability of the Company or any of its subsidiaries to enforce, license or exclude others from using
any Company Intellectual Property.
(u) Title
to Properties. The Company and its subsidiaries have good and marketable title in fee simple
to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business
of the Company and its subsidiaries, in each case free and clear of any lien, charge, pledge, security interest, encumbrance, right of
first refusal, preemptive right or other restriction (“Liens”), except for (i) as
set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (ii) Liens
as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and its subsidiaries and (iii) Liens for the payment of federal, state or other taxes that are not delinquent
or for which appropriate reserves have been made therefor in accordance with GAAP. Any real property and facilities held under lease by
the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance in all material respects.
8
(v) Taxes.
Except as would not be expected to have a Material Adverse Effect or except as disclosed in the
Registration Statement, the Pricing Disclosure Package or the Prospectus, (i) the Company
and its subsidiaries have paid all U.S. federal, state, local and non-U.S. taxes required to be paid by them through the date hereof unless
such taxes are being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance
with GAAP, (ii) the Company and its subsidiaries have filed all tax returns required to be paid or filed through the date hereof, and
(iii) there is no tax deficiency that has been, or would reasonably be expected to be, asserted against the Company or any of its subsidiaries
or any of their respective properties or assets.
(w) Insurance.
The Company and its subsidiaries have insurance covering their respective properties, operations,
personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and
risks as are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of
its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are
required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage.
(x) [Reserved.]
(y) Compliance
with Environmental Laws. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
(i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable federal, state, local and foreign
laws (including common law), rules, regulations, requirements, judgments, decrees, and orders relating to pollution or the protection
of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively,
“Environmental Laws”); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates
or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z) have
not received notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of,
any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or
wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any
such notice; (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries,
except in the case of each of (i) and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect; (iii) there is no proceeding that is pending, or that is known to be contemplated, against the Company
or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding
which it is reasonably believed no monetary sanctions of $300,000 or more will be imposed; (iv) the Company and its subsidiaries are not
aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws
or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that would reasonably be expected to have a material
effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries; and (v) none of the Company
or its subsidiaries anticipates material capital expenditures relating to any Environmental Laws.
(z) No
Rated Debt or Preferred Securities. There are no debt or preferred securities issued, or guaranteed, by the Company or its subsidiaries
that are rated by a “nationally recognized statistical rating organization,” as such term is defined in Section 3(a)(62)
of the Exchange Act.
9
(aa) ERISA Compliance.
Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect: (A) the Company and its
subsidiaries and any “employee benefit plan” (as defined under ERISA) established or maintained by the Company, its subsidiaries
or their “ERISA Affiliates” (as defined below) are in compliance with ERISA; (B) no “reportable event” (as defined
under ERISA), for which notice has not been waived, has occurred or is reasonably expected to occur with respect to any “employee
benefit plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates; (C) no “employee
benefit plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, if such “employee
benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined under ERISA); (D)
neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under
(1) Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (2) Sections 412,
4971, 4975 or 4980B of the Code; (E) each employee benefit plan established or maintained by the Company, its subsidiaries or any of their
ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company,
nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification. As used in this Section (aa),
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations
thereunder. “ERISA Affiliate” means, with respect to the Company or its subsidiaries, any member of any group of organizations
described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published
interpretations thereunder (the “Code”) of which the Company or its subsidiaries is a member.
(bb) Company Not an “Investment
Company.” The Company is not, and will not be, either after receipt of payment for the Shares or after the application of the
proceeds therefrom as described under “Use of Proceeds” in the Registration Statement, the Pricing Disclosure Package or the
Prospectus, required to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment
Company Act”).
(cc) No Price Stabilization
or Manipulation; Compliance with Regulation M. Neither the Company nor its subsidiaries have taken, directly or indirectly, without
giving effect to activities by the Underwriters, any action designed to or that would reasonably be expected to cause or result in stabilization
or manipulation of the price of the Shares or of any “reference security” (as defined in Rule 100 of Regulation M under the
Exchange Act (“Regulation M”)) with respect to the Shares, whether to facilitate the sale or resale of the Shares or otherwise,
and has taken no action which would directly or indirectly violate Regulation M.
(dd) Related-Party Transactions.
There are no business relationships or related-party transactions involving the Company or its subsidiaries or any other person required
to be disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus that have not been disclosed as required.
(ee) FINRA Matters.
All of the information provided to the Representative or to counsel for the Underwriters by the Company, its counsel, its officers and
directors and, to the Company’s knowledge, the holders of any securities (debt or equity) or options to acquire any securities of
the Company in connection with the offering of the Shares is true, complete, correct and compliant in all material respects with FINRA’s
rules and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules is true, complete and correct
in all material respects.
(ff) Parties to Lock-Up
Agreements. The Company has furnished to the Underwriters a letter agreement in the form attached hereto as Annex D (the “Lock-up
Agreement”) from each executive officer and director of the Company. If any additional persons shall become directors or officers
of the Company prior to the end of the 90-day restricted period referred to in Section 4(h) hereof, the Company shall cause each
such person, prior to or contemporaneously with their appointment or election as a director or officer of the Company, to execute and
deliver to the Representative a Lock-up Agreement.
(gg) Statistical and Market-Related
Data. All statistical, demographic and market-related data included in the Registration Statement, the Pricing Disclosure Package
or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate in all material respects.
(hh) No Unlawful Contributions
or Other Payments. Neither the Company nor its subsidiaries nor, to the best knowledge of the Company, any employee or agent of the
Company or its subsidiaries, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign
office in violation of any applicable law or of the character required to be disclosed in the Registration Statement, the Pricing Disclosure
Package or the Prospectus.
10
(ii) Foreign
Corrupt Practices Act. Neither the Company nor its subsidiaries nor, to the knowledge of the Company, any director, officer, agent,
employee, controlled affiliate or other person acting on behalf of the Company or its subsidiaries have, in the course of its actions
for, or on behalf of, the Company or its subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any domestic government
official, “foreign official” (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and
regulations thereunder, collectively, the “FCPA”) or employee from corporate funds; (iii) violated or is in violation of any
provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made any unlawful bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any domestic government official, such foreign official or employee; and the
Company and its subsidiaries and, to the knowledge of the Company, the Company’s other controlled affiliates have conducted their
respective businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which
are reasonably expected to continue to ensure, continued compliance therewith.
(jj) Money Laundering Laws.
The operations of the Company and its subsidiaries are, and have been conducted at all times, in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and
no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.
(kk) OFAC. Neither the
Company nor its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, controlled affiliate or person
acting on behalf of the Company or its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation,
the designation as a “specially designated national” or “blocked person,” the United Nations Security Council,
the European Union, His Majesty’s Treasury or other relevant sanctions authority (“Sanctions”), nor is the Company located,
organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran,
North Korea, Syria (prior to July 1, 2025), Russia, the so-called Donetsk People’s Republic, the so-called Luhansk People’s
Republic, the Crimea region of Ukraine and the non-government controlled areas of Zaporizhzhia and Kherson (each, a “Sanctioned
Country”); and the Company will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise make
available such proceeds to any subsidiary, or any joint venture partner or other person or entity, (i) for the purpose of financing the
activities of or business with any person, or in any country or territory, that currently is the subject of Sanctions, (ii) to fund or
facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any
person (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable Sanctions.
(ll) Brokers. Except
pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s
fee or other fee or commission as a result of any transactions contemplated by this Agreement.
(mm) Forward-Looking Statements.
Each financial or operational projection or other “forward-looking statement” (as defined by Section 27A of the Securities
Act or Section 21E of the Exchange Act) contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus
(i) was so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions,
estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements identifying those factors
that could cause actual results to differ materially from those in such forward-looking statement. No such statement was made with the
knowledge of an executive officer of the Company that it was false or misleading.
(nn) Compliance with Data
Privacy Laws. To the Company’s knowledge, the Company and its subsidiaries are, and at all prior times were, in material compliance
with all applicable state and federal data privacy and security laws and regulations (collectively, the “Privacy Laws”). To
ensure compliance with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take commercially reasonable
steps reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and
security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (as defined below) (the “Policies”).
The Company and its subsidiaries have at all times made all disclosures to users or customers required by the Privacy Laws, and none of
such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any Privacy
Laws in any material respect. The Company further certifies that neither it nor any subsidiaries: (i) have received written notice of
any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law;
or (iii) is a party to any order, decree, or agreement from or with a governmental or regulatory authority or agency that imposes any
obligation or liability under any Privacy Law.
11
(oo) Cybersecurity;
Data Protection. To the Company’s knowledge, the Company and its subsidiaries’ information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate
for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and
its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and
other corruptants. The Company and its subsidiaries have implemented and maintain commercially reasonable physical, technical and administrative
controls, policies, procedures, and safeguards designed to maintain and protect their material confidential information and the integrity,
continuous operation, redundancy and security of all IT Systems and data, including “Personal Data,” used in connection with
their businesses. “Personal Data” means (i) a natural person’s name, street address, telephone number, e-mail address,
photograph, social security number or tax identification number, driver’s license number, passport number, credit card number, bank
information, or customer or account number; (ii) any information which would qualify as “personally identifying information”
under the Federal Trade Commission Act, as amended; (iii) “personal data” as defined by GDPR, as applicable; (iv) any information
which would qualify as “protected health information” under HIPAA, as applicable; and (v) any other piece of information that
allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related to an
identified person’s health or sexual orientation. To the Company’s knowledge, there have been no breaches, violations, outages
or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to
notify any other person under applicable law, nor any incidents under review or investigations relating to the same. To the Company’s
knowledge, the Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized
use, access, misappropriation or modification.
(pp) Reserve Engineer.
MKM Engineering, whose reports appear or are incorporated by reference in the Registration Statement, the Pricing Disclosure Package and
the Prospectus and who has delivered the letter referred to in Section 6(f) hereof, was, as of the date of such report, and is, as
of the date hereof, an independent petroleum engineer with respect to the Company and its subsidiaries.
(qq) Reserve Report Information.
The information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding estimated proved
reserves of the Company and its subsidiaries is based upon the reserve reports prepared by MKM Engineering. The information provided to
MKM Engineering by the Company and its subsidiaries was true and correct in all material respects on the dates the reports were made.
Such information was provided to MKM Engineering in accordance with all customary industry practices.
(rr) Reserve Reports; Production
Estimates. The factual information underlying the estimates of reserves of the Company and its subsidiaries included in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, including, without limitation, production, costs of operation and development,
current prices for production, agreements relating to current and future operations and sales of production, was true and correct in all
material respects on the dates such estimates were made and such information was supplied and was prepared in accordance with customary
industry practices. Other than normal production of reserves, intervening market commodity price fluctuations, fluctuations in demand
for such products, adverse weather conditions, unavailability or increased costs of rigs, equipment, supplies or personnel, the timing
of third-party operations and other factors, in each case in the ordinary course of business, and except as described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries is aware of any facts or
circumstances that would result in a material adverse change in the aggregate net reserves, or the aggregate present value of future net
cash flows therefrom, as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(ss) [Reserved.]
12
(tt) Dividend Restrictions.
Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no subsidiary of the Company
is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with
respect to such subsidiary’s equity securities or from repaying to the Company or any other subsidiary of the Company any amounts
that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring any property
or assets to the Company or to any other subsidiary.
(uu) Sarbanes-Oxley.
The Company is, and after giving effect to the offering and sale of Shares will be, in compliance in all material respects with all applicable
effective provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission promulgated thereunder.
(vv) Margin Rules. Neither
the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in each of the Registration
Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal
Reserve System or any other regulation of such Board of Governors.
(ww) Status under the Securities
Act. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that
the Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the
Shares and at the date hereof, the Company was and is an “ineligible issuer,” in connection with the offering of the Shares
pursuant to Rules 164, 405 and 433 under the Securities Act.
4. Further
Agreements of the Company. The Company covenants and agrees with each Underwriter that:
(a) Required
Filings. The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule
430A, 430B or 430C under the Securities Act; and the Company will file within the time periods required by the Commission all reports
and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required
in connection with the offering or sale of the Shares; and the Company will furnish copies of the Prospectus to the Underwriters in New
York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as
the Representative may reasonably request.
(b) Delivery
of Copies. The Company will deliver, without charge, promptly upon request (i) to the Representative, two signed copies of the Registration
Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents
incorporated by reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed
and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies of the
Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) as the Representative may
reasonably request. As used herein, the term “Prospectus Delivery Period” means such period of time after the first date of
the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by
law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by
any Underwriter or dealer.
(c) Amendments
or Supplements. During the Prospectus Delivery Period, before filing any amendment or supplement to the Registration Statement, the
Pricing Disclosure Package or the Prospectus, the Company will furnish to the Representative and counsel for the Underwriters a copy of
the proposed amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such proposed
amendment or supplement to which the Representative reasonably object.
13
(d) Notice
to the Representative. The Company will advise the Representative promptly, and confirm such advice in writing (which confirmation
may be delivered by electronic mail), (i) when any amendment to the Registration Statement has been filed or becomes effective; (ii) when
any supplement to the Pricing Disclosure Package, the Prospectus, any Written Testing-the-Waters Communication or any amendment to the
Prospectus has been filed or distributed; (iii) of any request by the Commission for any amendment to the Registration Statement or any
amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or
any other request by the Commission for any additional information including, but not limited to, any request for information concerning
any Testing-the-Waters Communication; (iv) of the issuance by the Commission or any other governmental or regulatory authority of any
order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any
of the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters Communication or the initiation or, to the Company’s
knowledge, threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (v) of the occurrence
of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package
or any Written Testing-the-Waters Communication as then amended or supplemented would include any untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the
Prospectus, the Pricing Disclosure Package, any Written Testing-the-Waters Communication is delivered to a purchaser, not misleading;
and (vi) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale
in any jurisdiction or the initiation or, to the Company’s knowledge, threatening of any proceeding for such purpose; and the Company
will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement,
preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written
Testing-the-Waters Communication or suspending any such qualification of the Shares and, if any such order is issued, will use its reasonable
best efforts to obtain as soon as possible the withdrawal thereof.
(e) Ongoing
Compliance. (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist as a result
of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to
a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with applicable law, the Company will
promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and
furnish to the Underwriters and to such dealers as the Representative may designate such amendments or supplements to the Prospectus (or
any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the
Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will
not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus
will comply with applicable law and (2) if at any time prior to the Closing Date or any Additional Closing Date (i) any event or development
shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light
of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary
to amend or supplement the Pricing Disclosure Package to comply with applicable law, the Company will promptly notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish
to the Underwriters and to such dealers as the Representative may designate such amendments or supplements to the Pricing Disclosure Package
(or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in
the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure
Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with applicable law.
(f) Blue
Sky Compliance. The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions
if necessary as the Representative shall reasonably request and will continue such qualifications in effect so long as required for distribution
of the Shares; provided that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a
dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to
service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.
14
(g) Earnings
Statement. The Company will make generally available to its security holders and the Representative as soon as practicable an earnings
statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder
covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the “effective
date” (as defined in Rule 158) of the Registration Statement; provided that the Company will be deemed to have furnished such statements
to its security holders and the Representative to the extent they are filed on EDGAR or any successor system.
(h) Clear
Market. For a period of 90 days after the date of the Prospectus (the “Lock-Up Period”), the Company will not (i) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, hedge, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission
a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or
exchangeable for Stock (including, for the avoidance of doubt, the filing of a preliminary prospectus supplement or final prospectus supplement
for an at-the-market offering), or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any hedging,
swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other
securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock
or such other securities, in cash or otherwise, without the prior written consent of the Representative, other than the Shares to be sold
hereunder.
The restrictions described above
do not apply to (i) the issuance of shares of Stock or securities convertible into or exercisable for shares of Stock pursuant to
the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or
the vesting or settlement of restricted stock, restricted stock units or performance units (including net settlement), in each case outstanding
on the date of this Agreement and described in the Prospectus; (ii) the issuance of shares of Stock or securities convertible into or
exercisable for shares of Stock as consideration for the acquisition of equity interests or assets of any person, or the acquiring by
the Company by any other manner of any business, properties, assets, or persons, or in connection with a joint-venture or other strategic
transaction, whether in one transaction or a series of related transactions, in an aggregate amount not to exceed 5% of the Company’s
outstanding Stock as of the date hereof; (iii) grants of stock options, stock awards, restricted stock, restricted stock units,
performance units, or other equity awards and the issuance of shares of Stock or securities convertible into or exercisable or exchangeable
for shares of Stock (whether upon the exercise of stock options or otherwise) to the Company’s employees, officers, directors, advisors,
or consultants pursuant to the terms of an inducement plan or an equity compensation plan, or employee stock purchase plan in effect as
of the Closing Date and described in the Prospectus; (iv) the filing of any registration statement on Form S-8 relating to
securities granted or to be granted pursuant to any plan in effect on the date of this Agreement and described in the Prospectus or any
assumed benefit plan pursuant to an acquisition or similar strategic transaction; (v) the filing of any registration statement on Form
S-3 providing for the resale of Company securities held by Macquarie Equipment Capital, Inc., SharonAI, Inc., Zachary Zhou or any stockholder
issued shares of Stock or securities convertible into or exercisable for shares of Stock pursuant to clause (ii), or any shares of Stock
or securities exercisable for shares of Stock issued in connection with the Company’s contemplated term loan with Macquarie Equipment
Capital, Inc.
Notwithstanding the foregoing,
the Lock-Up Period shall be reduced to a period of 60 days after the date of the Prospectus as it relates to the filing a registration
statement under the Securities Act or the filing of a preliminary prospectus supplement or final prospectus supplement under the Securities
Act, in either case, related to an at-the-market offering, or the sale of any shares of Stock pursuant to an at-the-market offering.
(i) Use
of Proceeds. The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus under the heading “Use of Proceeds.”
(j) No
Stabilization. Neither the Company nor its subsidiaries will take, and the Company will ensure that its controlled affiliates will
not take, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization
or manipulation of the price of the Stock and will not take any action prohibited by Regulation M under the Exchange Act in connection
with the distribution of the Shares contemplated hereby.
(k) Exchange
Listing. The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on the Nasdaq.
15
(l) Reports.
For a period of two years from the date of this Agreement, so long as the Shares are outstanding, the Company will furnish to the Representative,
as soon as commercially reasonable after the date on which they are available, copies of all reports or other communications (financial
or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission
or any national securities exchange or automatic quotation system; provided the Company will be deemed to have furnished such reports
and financial statements to the Representative to the extent they are filed on EDGAR or any successor system.
(m) Emerging
Growth Company. The Company will promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any
time prior to the later of (i) completion of the distribution of Shares within the meaning of the Securities Act and (ii) completion
of the 90-day restricted period referred to in Section 4(h) hereof.
5. Certain
Agreements of the Underwriters. Each Underwriter hereby represents and agrees that:
(a) It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any “free writing prospectus,”
as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission
by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than
a free writing prospectus that contains no “issuer information” (as defined in Rule 433(h)(2) under the Securities
Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus.
(b) It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms
of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; provided
that Underwriters may use a term sheet substantially in the form of Annex C hereto without the consent of the Company; provided further
that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or
substantially concurrently with, the first use of such term sheet.
(c) It
is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify
the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).
6. Conditions
of Underwriters’ Obligations. The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or
the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company
of its covenants and other obligations hereunder and to the following additional conditions:
(a) Registration
Compliance; No Stop Order. No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, or pursuant to Section 8A under the Securities Act shall be pending before or threatened by the Commission; the
Prospectus and any free writing prospectus shall have been timely filed with the Commission under the Securities Act, to the extent required
by Rule 433 under the Securities Act and in accordance with Section 4(a) hereof; and all requests by the Commission for
additional information shall have been complied with to the reasonable satisfaction of the Representative.
(b) Representations
and Warranties. The representations and warranties of the Company contained herein shall be true and correct on the date hereof and
on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made
in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing
Date, as the case may be.
(c) No
Material Adverse Change. No event or condition of a type described in Section 3(h) hereof shall have occurred or shall
exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and
the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representative makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Underwritten Shares on the Closing Date or the Option
Shares on the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing
Disclosure Package and the Prospectus.
16
(d) Officer’s
Certificate. The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may
be, a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer
of the Company who is satisfactory to the Representative (i) confirming that such officers have carefully reviewed the Registration
Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in
Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations and warranties
of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions
on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be,
and (iii) to the effect set forth in paragraphs (a), (b) and (c) above.
(e) Comfort
Letters. On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Weaver and Tidwell,
L.L.P. shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof
and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, containing statements and information
of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements
and certain financial information contained or incorporated by reference in each of the Registration Statement, the Pricing Disclosure
Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be,
shall use a “cut-off” date no more than three business days prior to such Closing Date or such Additional Closing Date, as
the case may be.
(f) Reserve
Engineer Letters. On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, MKM Engineering
shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, (a) containing statements and information
of the type customarily included in reserve engineers’ “comfort letters” stating the conclusions and findings of such
firm with respect to certain of the oil and natural gas reserves of the Company and certain other related information included or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (b) stating that such firm is, as of
the date thereof, an independent reserve engineer with respect to the Company; provided, that the letter delivered on the Closing Date
or the Additional Closing Date, as the case may be, shall use a “cut-off” date no more than three business days prior to such
Closing Date or such Additional Closing Date, as the case may be.
(g) Opinion
and Negative Assurance Letter of Counsel for the Company. Vinson & Elkins, L.L.P., counsel for the Company, shall have furnished
to the Representative, at the request of the Company, its written opinion and negative assurance letter, dated the Closing Date or the
Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative.
(h) Opinion
of Nevada Counsel for the Company. Anthony, Linder & Cacomanolis, PLLC, Nevada counsel for the Company, shall have furnished to
the Representative, at the request of the Company, its written opinion, dated the Closing Date or the Additional Closing Date, as the
case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative.
(i) Opinion of Counsel for
the Underwriters. The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case
may be, an opinion that shall contain a negative assurance statement, addressed to the Underwriters, of Faegre Drinker Biddle & Reath
LLP, counsel for the Underwriters, with respect to such matters as the Representative may reasonably request, and such counsel shall
have received such documents and information as they may reasonably request to enable them to pass upon such matters.
17
(j) No
Legal Impediment to Issuance and Sale. No action shall have been taken and no statute, rule, regulation or order shall have been enacted,
adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional
Closing Date, as the case may be, prevent the issuance or sale of the Shares by the Company; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date by Company, as the case
may be, prevent the issuance or sale of the Shares.
(k) Good
Standing. The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be,
satisfactory evidence of the good standing of the Company in its jurisdiction of organization.
(l) Lock-up
Agreements. The “lock-up” agreements, each substantially in the form of Annex D hereto, executed by certain officers and
directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered to
the Representative on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date,
as the case may be.
(m) Exchange
Listing. The Company shall have submitted a Listing of Additional Shares notification to the Nasdaq with respect to the Shares.
(n) Additional
Documents. On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to
the Representative such further certificates and documents as the Representative may reasonably request.
All opinions, letters, certificates
and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they
are in form and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification
and Contribution.
(a) Indemnification
of the Underwriters. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and
each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable and documented
legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any claim asserted, as such fees
and expenses are incurred), joint or several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii) any untrue statement
or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus,
any “issuer information” filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Written
Testing-the-Waters Communication, any road show as defined in Rule 433(h) under the Securities Act (a “road show”)
or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission
or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or
are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with
any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly
for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information
described as such in paragraph (b) below.
18
(b) Indemnification
of the Company. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its
officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above,
but only with respect to any losses, claims, damages or liabilities (including, without limitation, reasonable and documented legal fees
and other expenses incurred in connection with any suit, action, or proceeding or any claim asserted, as such fees and expenses are incurred)
that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and
in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representative
expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus,
any Written Testing-the-Waters Communication, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package
that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists
of the following information in the Prospectus furnished on behalf of each Underwriter: (i) the concession figure appearing in the second
paragraph under the caption “Underwriting,” (ii) paragraphs one, two and three under the caption “Price Stabilization,
Short Position and Penalty Bids,” and (iii) the second, third and fourth sentences in the first paragraph under “Electronic
Offer, Sale and Distribution.”
(c) Notice
and Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section 7, such person (the “Indemnified Person”) shall promptly notify the person against whom such indemnification
may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall
not relieve it from any liability that it may have under the preceding paragraphs of this Section 7 except to the extent that it
has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise
than under the preceding paragraphs of this Section 7. If any such proceeding shall be brought or asserted against an Indemnified
Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory
to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent
the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate
in such proceeding and shall pay the reasonably incurred and documented fees and expenses in such proceeding and shall pay the reasonably
incurred and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified
Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the
Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the
Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition
to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties)
include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection
with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm
(in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they
are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter
shall be designated in writing by the Representative and any such separate firm for the Company, its directors, its officers who signed
the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person
shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if
there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any
loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person
shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by
this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such
settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying
Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying
Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in
respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified
Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably
satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does
not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.
19
(d) Contribution.
If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or insufficient
in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu
of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result
of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received
by the Company, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if the allocation provided
by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i) but also the relative fault of the Company, on the one hand, and the Underwriters on the other, in
connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant
equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be
deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale
of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case
as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the
Company, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied
by the Company or by the Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission.
(e) Limitation
on Liability. The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to paragraph (d) above
were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method
of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid
or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above
shall be deemed to include, subject to the limitations set forth above, any reasonable and documented legal or other expenses incurred
by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d) and
(e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts
and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter
has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. The Underwriters’ obligations to contribute pursuant to
paragraphs (d) and (e) are several in proportion to their respective purchase obligations hereunder and not joint.
(f) Non-Exclusive
Remedies. The remedies provided for in this Section 7 paragraphs (a) through (e) are not exclusive and shall
not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.
8. Effectiveness
of Agreement. This Agreement shall become effective as of the date first written above upon the execution and delivery hereof by the
parties hereto.
20
9. Termination.
This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Company, if after the execution and
delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date
(i) trading generally shall have been suspended or materially limited on or by either of the New York Stock Exchange or the Nasdaq;
(ii) trading of any securities issued by the Company shall have been suspended on any exchange or in any over-the-counter market;
(iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or
(iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis,
either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable
or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the
case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
10. Defaulting
Underwriter.
(a) If,
on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Shares
that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase
of such Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such
default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase
such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting
Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business
days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in
the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any
amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the
term “Underwriter” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed
in Schedule I hereto that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to
purchase.
(b) If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on
the Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to
be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of
Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter’s pro rata share (based on the number
of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which
such arrangements have not been made.
(c) If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on
the Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased
on such date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with
respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case
may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to
this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the
payment of expenses as set forth in Section 11 hereof (other than with respect to the defaulting Underwriter(s)) and except that
the provisions of Section 7 hereof shall not terminate and shall remain in effect.
21
11. Payment
of Expenses.
(a) Whether
or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause
to be paid the following: (i) the fees, disbursements and expenses of the Company’s counsel and accountants in connection with
the registration of the Shares under the Securities Act and all other expenses in connection with the preparation, printing, reproduction
and filing of the Registration Statement, the Preliminary Prospectus, any Pricing Disclosure Package and the Prospectus (including all
exhibits, amendments and supplements thereto) and the distribution thereof; (ii) the cost of printing or producing this Agreement,
the Blue Sky survey, closing documents (including any compilations thereof) and any other documents in connection with the offering, purchase,
sale and delivery of the Shares; (iii) all expenses in connection with the qualification of the Shares for offering and sale under
state securities laws; (iv) all fees and expenses in connection with listing the Shares on the Nasdaq; (v) the filing fees incident
to and in connection with, any required review by FINRA of the terms of the sale of the Shares; (vi) the cost of preparing stock
certificates, if applicable; (vii) the cost and charges of any transfer agent, or registrar; (viii) the costs and expenses of
the Company relating to investor presentations on any “road show” undertaken in connection with the marketing of the Shares,
including without limitation, expenses associated with the production of road show slides and graphics, fees; and (ix) all other
costs and expenses incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this
Section 11. It is understood, however, that, except as provided in this Section 11 and Section 7 hereof, the Underwriters
will pay all of their own costs and expenses; provided, however, that the Company will reimburse the Representative for all out-of-pocket
expenses (including fees and expenses of its counsel) reasonably incurred and documented by it in connection with its engagement hereunder
in an aggregate amount that shall not exceed $150,000 without the prior written approval of the Company.
(b) If
(i) this Agreement is terminated pursuant to Section 9 (other than by reason of a default by any Underwriter pursuant to Section 10),
(ii) the Company for any reason fails to tender the Shares for delivery to the Underwriters (other than by reason of a default by
any Underwriter pursuant to Section 10) or (iii) the Underwriters decline to purchase the Shares for any reason permitted under
this Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and expenses
of their counsel) reasonably incurred and documented by the Underwriter in connection with this Agreement and the offering contemplated
hereby. For the avoidance of doubt, it is understood that the Company shall not pay or reimburse any costs, fees or expenses incurred
by any Underwriter that defaults on its obligation to purchase the Shares.
12. Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred
to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable
right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter
shall be deemed to be a successor merely by reason of such purchase.
13. Survival.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained
in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination
of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling
persons or affiliates referred to in Section 7 hereof.
14. Certain
Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term “affiliate”
has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other
than a day on which banks are permitted or required to be closed in New York City and (c) the term “subsidiary” has
the meaning set forth in Rule 405 under the Securities Act.
15. Compliance
with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26,
2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the
Company, which information may include the name and address of their respective clients, as well as other information that will allow
the Underwriters to properly identify their respective clients.
22
16. Miscellaneous.
(a) Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriter shall be given to the Underwriter c/o Northland Securities,
Inc., 1150 South Fifth Street, Suite 3300, Minneapolis, MN 55402, with a copy (which shall not constitute notice) to Faegre Drinker Biddle & Reath LLP, 2200 Wells Fargo Center 90 S. Seventh Street, Minneapolis, Minnesota 55402, Attention: Jonathan Zimmerman. Notices to
the Company shall be given to it at 200 N. Loraine Street, Suite 1324, Midland, Texas 79701, Attention: E. Will Gray II, with a copy to
Vinson & Elkins, L.L.P., 2001 Ross Avenue, Suite 3900, Dallas, Texas 75201, Attention: Katherine Terrell Frank.
(b) Governing
Law. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York.
(c) Submission
to Jurisdiction. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough
of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such
courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding
upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment.
(d) Waiver
of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby.
(e) Recognition
of the U.S. Special Resolution Regimes.
(i) In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.
(ii) In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.
As used in this Section 16(e):
“BHC Act Affiliate”
has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
“Covered Entity”
means any of the following:
(iii) a
“covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(iv) a
“covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(v) a
“covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
23
“Default Right” has the meaning
assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
“U.S. Special Resolution Regime”
means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank
Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
(f) Counterparts.
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument. This Agreement may be delivered
via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com
or www.echosign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.
(g) Amendments
or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.
(h) Headings.
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement.
24
If the foregoing is in accordance
with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.
Very truly yours,
New Era Energy & Digital, Inc.
By:
/s/ E. Will Gray II
Name: E. Will Gray II
Title: Chief Executive Officer
Accepted: As of the date first written above
Northland Securities, Inc.
For itself and on behalf of the several Underwriters
listed in Schedule I hereto.
By:
/s/ David Levine
Name: David Levine
Title: Head of Investment Banking
Signature Page to Underwriting Agreement
SCHEDULE I
Underwriter
Number of
Shares
Northland Securities, Inc.
23,880,597
TCBI Securities, Inc., doing business as Texas Capital Securities
5,970,149
Total:
29,850,746
Schedule I to Underwriting Agreement
SCHEDULE II
Significant Subsidiaries
1. New Era Helium Corp.
2. Solis Partners, L.L.C.
3. NEH Midstream LLC.
4. Texas Critical Data Centers LLC.
Schedule II to Underwriting Agreement
ANNEX A
a. Pricing
Disclosure Package
None.
b. Pricing
Information Provided Orally by the Underwriter
Public Offering Price per Share: $3.35
Number of Underwritten Shares: 29,850,746
Number of Option Shares: 4,477,611
Annex A to Underwriting Agreement
ANNEX B
Written Testing-the-Waters Communications
None.
Annex B to Underwriting Agreement
ANNEX C
New Era Energy & Digital, Inc.
Pricing Term Sheet
None.
Annex C to Underwriting Agreement
ANNEX D
FORM OF LOCK-UP AGREEMENT
[●], 2026
NORTHLAND SECURITIES, INC.
As Representative of the several Underwriters
listed in Schedule I to the Underwriting Agreement
referred to below
c/o Northland Securities, Inc.
150 South Fifth Street, Suite 3300
Minneapolis, Minnesota 55402
Re:
New Era Energy & Digital, Inc. — Public Offering
Ladies and Gentlemen:
The undersigned understands that
you, as Representative of the several Underwriters, propose to enter into an underwriting agreement (the “Underwriting Agreement”)
with New Era Energy & Digital, Inc., a Nevada corporation (the “Company”), providing for the public offering (the “Public
Offering”) by the Underwriters listed in Schedule I to the Underwriting Agreement (the “Underwriters”), of shares
of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Securities”). Capitalized
terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
In consideration of the Underwriters’
agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is
hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Representative, the undersigned will
not, and will not cause any direct or indirect affiliate to, during the period beginning on the date hereof and ending at the close of
business 90 days after the date of the final prospectus supplement relating to the Public Offering (such period, the “Restricted
Period”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of
Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common
Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations
of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively
with the Common Stock, the “Lock-Up Securities”), (2) enter into any hedging, swap or other agreement or transaction that
transfers, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for
or exercise any right with respect to the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of
the foregoing. The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other
transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call
option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed
or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned
or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities,
whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Lock-Up Securities,
in cash or otherwise.
Notwithstanding the foregoing,
the undersigned may:
(a) transfer or dispose of the
undersigned’s Lock-Up Securities:
(i) as a bona fide gift or gifts,
or for bona fide tax planning or estate planning purposes,
(ii) by will or intestacy,
(iii) to any trust for the direct
or indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is a trust, to a trustor or beneficiary
of the trust or to the estate of a beneficiary of such trust (for purposes of this Lock-Up Agreement, “immediate family” shall
mean any relationship by blood, current or former marriage, domestic partnership or adoption, not more remote than first cousin),
(iv) to a corporation, partnership,
limited liability company or other entity of which the undersigned or the immediate family of the undersigned are the legal and beneficial
owner of all of the outstanding equity securities or similar interests,
(v) to a nominee or custodian
of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,
(vi) if the undersigned is a
corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited
liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of
1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or
under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned
is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as
part of a distribution or transfer to members, partners, shareholders or other equityholders of the undersigned,
(vii) by operation of law, such
as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or related court order,
(viii) to the Company from an
employee of the Company upon death, disability or termination of employment, in each case, of such employee,
(ix) as part of a sale of the
undersigned’s Lock-Up Securities acquired in the Public Offering and any transaction with respect to shares of Common Stock acquired
in open market transactions after the completion of the Public Offering,
(x) to the Company in connection
with the vesting, settlement, or exercise of restricted stock, restricted stock units, performance units options, warrants or other rights
to purchase shares of Common Stock (including, in each case, by way of “net” or “cashless” exercise), including
for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted
stock, restricted stock units, performance units, options, warrants or rights, provided that any such shares of Common Stock received
upon such exercise, vesting or settlement (other than such shares as are transferred or surrendered to the Company in connection with
such vesting, settlement or exercise event) shall be subject to the terms of this Lock-Up Agreement, and provided further that any such
restricted stock, restricted stock units, performance units, options, warrants or rights are held by the undersigned pursuant to an agreement
or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, or
(xi) pursuant to a bona fide
third-party tender offer, merger, consolidation, stock exchange or other similar transaction that is approved by the Board of Directors
of the Company and made to all holders of the Company’s capital stock involving a Change of Control of the Company. For purposes
hereof, “Change of Control” shall mean the transfer (whether by tender offer, merger, consolidation, stock exchange or other
similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the
Underwriters pursuant to the Public Offering), of shares of capital stock if, after such transfer, such person or group of affiliated
persons would hold more than 50% of the outstanding voting securities of the Company (or the surviving entity); provided that in the event
that such tender offer, merger, consolidation, stock exchange or other similar transaction is not completed, the undersigned’s Lock-Up
Securities shall remain subject to the provisions of this Lock-Up Agreement;
provided that (A) in the case
of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v) and (vi), such transfer shall not involve a disposition
for value, (B) in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), each donee,
devisee, transferee or distributee shall execute and deliver to the Representative a lock-up letter in the form of this Lock-Up Agreement,
(C) in the case of any transfer or distribution pursuant to clause (a)(ii), (iv), (v), and (vi), no filing by any party (donor, donee,
devisee, transferor, transferee, distributer or distributee) under the Exchange Act, or other public announcement reporting a reduction
in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily in connection with such transfer or distribution
(other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above) and (D) in the case of any transfer
or distribution pursuant to clauses (a)(i), (iii), (vii), (viii), (ix), and (x) it shall be a condition to such transfer that no public
filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act, or other public filing,
report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection with such transfer or distribution
shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate the nature and conditions
of such transfer in the footnotes thereto or by transaction code;
(b) exercise outstanding options
or warrants, or settle restricted stock, restricted stock units, performance units or other equity awards pursuant to plans described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-up Securities received upon such
exercise, vesting or settlement shall be subject to the terms of this Lock-Up Agreement; provided that if the undersigned is required
to make any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement during the Restricted Period,
the undersigned shall clearly indicate that the filing relates to the circumstances described in this clause by footnotes thereto or transaction
code and that the shares of Common Stock received upon the exercise, vesting or settlement, as applicable, are subject to this Lock-Up
Agreement, and no public filing, report or announcement shall be voluntarily made; and
(c) establish trading plans pursuant
to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities (each such plan, a “Trading Plan”);
provided that such (1) Trading Plans do not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) no filing
by any party under the Exchange Act or other public announcement shall be made voluntarily during the Restricted Period in connection
with such trading plan and if any such filing or public announcement shall be legally required during the Restricted Period, such filing
or public announcement shall clearly indicate therein that none of the securities subject to such plan may be transferred, sold or otherwise
disposed of pursuant to such plan until after expiration of the Restricted Period.
If the undersigned is not a natural
person, the undersigned represents and warrants that no single natural person, entity or “group” (within the meaning of Section
13(d)(3) of the Exchange Act) other than a natural person, entity or “group” (as described above) that has executed a Lock-Up
Agreement in substantially the same form as this Lock-Up Agreement, beneficially owns, directly or indirectly, 50% or more of the common
equity interests, or 50% or more of the voting power, in the undersigned.
In furtherance of the foregoing,
the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized
to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Lock-Up Agreement.
The undersigned hereby represents
and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or
agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives
of the undersigned.
The undersigned acknowledges
and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action
from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted its own legal, accounting,
financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although
each Underwriter may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with
the Public Offering, none of the Representative or any other Underwriter is making a recommendation to you to enter into this Lock-Up
Agreement and nothing set forth in such disclosures is intended to suggest that the Representative or any other Underwriter is making
such a recommendation.
The undersigned understands that,
(i) if the Underwriting Agreement does not become effective by April 30, 2026, (ii) if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder,
(iii) the Company notifies the Representative, or the Representative notifies the Company, in writing prior to the execution of the Underwriting
Agreement that it does not intend to proceed with the Public Offering, or (iv) prior to payment for the Securities, the Registration Statement
is withdrawn prior to the execution of the Underwriting Agreement, the Lock-Up Agreement shall automatically terminate and be of no further
force or effect and undersigned shall be released from all obligations under this Lock-Up Agreement. The undersigned understands that
the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Lock-Up Agreement.
The undersigned hereby consents
to receipt of this Lock-Up Agreement in electronic form and understands and agrees that this Lock-Up Agreement may be signed electronically.
In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission (including
any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) evidencing an intent to sign
this Lock-Up Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a valid and binding
obligation of the undersigned with the same force and effect as if such signature were an original. Execution and delivery of this Lock-Up
Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes.
[Signature page follows]
This Lock-Up Agreement and any claim, controversy or
dispute arising under or related to this Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State
of New York.
Very truly yours,
Name of Security Holder (Print exact name)
By:
Signature
If not signing in an individual capacity:
Name of Authorized Signatory (Print)
Title of Authorized Signatory (Print)
(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)
[Signature page to Lock-Up Agreement]
EX-5.1 — OPINION OF ANTHONY, LINDER & CACOMANOLIS, PLLC
EX-5.1
Filename: ea028575601ex5-1.htm · Sequence: 3
Exhibit 5.1
LAURA ANTHONY, ESQ.
CRAIG D. LINDER, ESQ.*
JOHN CACOMANOLIS, ESQ.**
Associates and OF COUNSEL:
JOSEPHINE CARINO, ESQ.***
CHAD FRIEND, ESQ., LLM
MICHAEL R. GEROE, ESQ., CIPP/US****
JESSICA HAGGARD, ESQ. *****
PETER P. LINDLEY, ESQ., CPA,
MBA
JOHN LOWY, ESQ.*******
STUART REED, ESQ.
LAZARUS ROTHSTEIN, ESQ.
SVETLANA ROVENSKAYA, ESQ.********
HARRIS TULCHIN, ESQ. *********
WWW.ALCLAW.COM
WWW.SECURITIESLAWBLOG.COM
*licensed in CA, FL and NY
**licensed in FL and NY
*** licensed in CA
****licensed in CA, DC, MO and NY
*****licensed in Missouri
*******licensed in NY and NJ
********licensed in NY and NJ
*********licensed in CA and HI (inactive in HI)
April 9, 2026
New Era Energy & Digital, Inc.
200 N. Loraine Street, Suite 1324
Midland, TX 79701
Re:
New Era Energy & Digital, Inc. Offering
Ladies and Gentlemen:
We have acted as securities counsel
to New Era Energy & Digital, Inc., a Nevada corporation (the “Company”) in connection with its filing of a prospectus
supplement, dated April 9, 2026 (the “Prospectus Supplement”), under the registration statement on Form S-3 (File No. 333-292892)
(the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) under the
Securities Act of 1933, as amended (the “Securities Act”), relating to the proposed offering of up to 34,328,357 shares (the
“Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Shares will be
offered, issued and sold pursuant to an underwriting agreement, dated April 9, 2026, by and between the Company and Northland Securities,
Inc., as representative of the several underwriters named in Schedule I thereto (the “Underwriting Agreement”).
In rendering our opinion set forth
below, we have reviewed such corporate documents and records of the Company, such certificates of public officials and such other matters
as we have deemed necessary or appropriate for purposes of this opinion letter. As to facts material to the opinion expressed herein,
we have relied upon oral and written statements and representations of officers and other representatives of the Company and relied on
certificates of public officials. We also have assumed (a) the authenticity of all documents submitted to us as originals; (b) the conformity
to the originals of all documents submitted to us as copies; (c) the genuineness of all signatures; (d) the legal capacity of natural
persons; and (e) the truth, accuracy and completeness of the information, factual matters, representations and warranties contained in
all of such documents.
Based upon and subject to the
foregoing, and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that the Shares, when
issued and delivered against payment therefor in accordance with the Underwriting Agreement, have been validly issued, fully paid and
nonassessable.
The opinions expressed in this
opinion letter are limited to the Private Corporations Law of the State of Nevada and the reported judicial decisions interpreting such
statute and provisions and the laws of the state of New York and the federal laws of the United States of America. We are not opining
on, and we assume no responsibility for, the applicability to or effect on any of the matters covered herein of (a) any other laws of
the State of Nevada; (b) the laws of any other jurisdiction; or (c) the laws of any county, municipality or other political subdivision
or local governmental agency or authority.
This opinion is given as of the
date hereof, and we assume no obligation to advise you after the date hereof of facts or circumstances that come to our attention or changes
in law that occur which could affect the opinion contained herein. This opinion is being rendered for the benefit of the Company in connection
with the matters addressed herein.
We hereby consent to the filing
of this opinion letter with the Commission as Exhibit 5.1 to the Company’s Current Report on Form 8-K, to be filed on or about the
date hereof, and to the reference to our firm therein and in the Prospectus Supplement under the caption “Legal Matters.”
In giving such consent, we do not thereby admit that this firm is within the category of persons whose consent is required under Section
7 of the Securities Act or the rules and regulations of the Commission thereunder.
Sincerely yours,
/s/ Laura E. Anthony
Laura E. Anthony,
For the Firm
1700 PALM BEACH LAKES BLVD.,
SUITE 820 ● WEST PALM BEACH, FLORIDA ● 33401
● PHONE: 561-514-0936
EX-99.1 — PRESS RELEASE, DATED APRIL 9, 2026
EX-99.1
Filename: ea028575601ex99-1.htm · Sequence: 4
Exhibit 99.1
New Era Energy & Digital Announces Pricing of $100 Million Public
Offering of Common Stock
MIDLAND, Texas – April 9, 2026 –
New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI) today announced the pricing of
its previously announced underwritten public offering of 29,850,746 shares of its common stock, par value $0.0001 per share (“Common
Stock”), at a price to the public of $3.35 per share, resulting in gross proceeds to the Company of approximately $100 million,
before deducting the underwriters’ discount and commissions and estimated offering fees and expenses, pursuant to an effective shelf
registration statement on Form S-3 (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission (the
“SEC”).
The Company intends to use the net proceeds it
receives from the offering to repay all outstanding borrowings under a senior secured convertible promissory note payable to SharonAI,
Inc. and the remainder, if any, for general corporate purposes.
The Company has granted the underwriters a 30-day
option to purchase up to an additional 4,477,611 shares of Common Stock at the public offering price, less the underwriting discounts
and commissions.
Northland Capital Markets is serving as lead book-running
manager for the offering. Texas Capital Securities is acting as book-running manager for the offering. The offering is expected to close
on April 10, 2026, subject to customary closing conditions.
The offering is being made only by means of a
prospectus and a final prospectus supplement that meet the requirements under the Securities Act of 1933, as amended. Copies of the final
prospectus supplement and accompanying base prospectus relating to the offering may be obtained from: Northland Securities, Inc., 150
South Fifth Street, Suite 3300, Minneapolis, MN, Attention: Heidi Fletcher, by telephone at (612) 851-4918 or by accessing the SEC’s
website at www.sec.gov.
The offering is being conducted pursuant to the
Registration Statement (File No. 333-292892), which was filed on January 23, 2026, and declared effective by the SEC on January 30, 2026,
and corresponding prospectus. A preliminary prospectus supplement thereto has been filed with the SEC. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy the shares of Common Stock or any other securities, nor shall there be any sale
of such shares of Common Stock or any other securities in any state or other jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About New Era Energy & Digital, Inc.
New Era is a developer
and operator of next-generation digital infrastructure and integrated power assets.
Contacts:
New Era Energy &
Digital, Inc. Investor and Media Contact:
OG Advisory Group
Lincoln Tan
nuai@orangegroupadvisors.com
Forward-Looking Statements
This press release
contains “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used
in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,”
“intend,” “plan” or the negative of these terms and similar expressions, as they relate to us or our management,
identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating
to the offering and the use of proceeds therefrom. Forward-looking statements are based on our current expectations and assumptions regarding
our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent
uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated
by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We
caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to
differ materially from those in the forward-looking statements include, without limitation, the risks contained in the “Risk Factors”
section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Should one or more of these risks or uncertainties
materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned. Factors or events that could cause our actual results to differ may emerge from time to time,
and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements.
Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking
statements to conform these statements to actual results.
GRAPHIC
GRAPHIC
Filename: ea028575601_ex5-1img1.jpg · Sequence: 5
Binary file (8783 bytes)
Download ea028575601_ex5-1img1.jpg
GRAPHIC
GRAPHIC
Filename: ea028575601_ex99-1img1.jpg · Sequence: 6
Binary file (5741 bytes)
Download ea028575601_ex99-1img1.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 12
v3.26.1
Cover
Apr. 09, 2026
Document Type
8-K
Amendment Flag
false
Document Period End Date
Apr. 09, 2026
Entity File Number
001-42433
Entity Registrant Name
NEW ERA ENERGY & DIGITAL, INC.
Entity Central Index Key
0002028336
Entity Tax Identification Number
99-3749880
Entity Incorporation, State or Country Code
NV
Entity Address, Address Line One
200 N. Loraine Street
Entity Address, Address Line Two
Suite 1324
Entity Address, City or Town
Midland
Entity Address, State or Province
TX
Entity Address, Postal Zip Code
79701
City Area Code
432
Local Phone Number
695-6997
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
Common Stock [Member]
Title of 12(b) Security
Common Stock
Trading Symbol
NUAI
Security Exchange Name
NASDAQ
Warrants
Title of 12(b) Security
Warrants
Trading Symbol
NUAIW
Security Exchange Name
NASDAQ
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=NUAI_WarrantsMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: